Stephen L. Huhn Contineum Therapeutics, Inc. (CTNM) insider trading activity

CTNM Quotes by TradingView
Shares Held (Direct Ownership) 12.8K
n/a 3M change
n/a 12M change
Total Value Held N/A

Stephen L. Huhn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 13 2024
BUY
Exercise of conversion of derivative security
$12,928 $1.01 p/Share
12,800 Added 50.0%
12,800 Class A Common Stock
SLH

Stephen L. Huhn

CMO & Sr VP, Clinical Dev.
San Diego, CA

Track Institutional and Insider Activities on CTNM

Follow Contineum Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTNM shares.

Notify only if

Insider Trading

Get notified when an Contineum Therapeutics, Inc. insider buys or sells CTNM shares.

Notify only if

News

Receive news related to Contineum Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTNM